Aspirin for primary prevention. Doctors and patients should understand potential benefits and risks of aspirin treatment.
Alkhenizan
A
A
D001241:Aspirin / Q000627:therapeutic use*; D001364:Awareness; D002986:Clinical Trials as Topic; D006801:Humans; D007258:Informed Consent; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin